R. Michael Garavito
- Pharmacology top 0.05%
- Inflammatory mediators and NSAID effects 28
- Biochemistry top 0.1%
- Eicosanoids and Hypertension Pharmacology 9
- Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects 28
- Structural Biology top 2%
- Molecular Biology top 1%
- Lipid Membrane Structure and Behavior 19
- Protein Structure and Dynamics 14
- Photosynthetic Processes and Mechanisms 12
- RNA and protein synthesis mechanisms 10
-
- Enzyme Structure and Function 22
-
- Estrogen and related hormone effects 11
- Co-authors
- William L. SmithDavid L. DeWittDaniel PicotPatrick J. LollShelagh Ferguson‐MillerA. M. MulichakW. VilligerEric Carlemalm
- Cited by
- PharmacologyBiochemistry
- Journals
- Nature (1 paper)Science (3 papers)Proceedings of the National Academy of Sciences (4 papers)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
R. Michael Garavito
104 papers receiving 12.5k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Pharmacology 4.9k
- Biochemistry 1.7k
- Pharmacology 788
- Structural Biology 123
- Molecular Biology 6.0k
Countries citing papers authored by R. Michael Garavito
This map shows the geographic impact of R. Michael Garavito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Michael Garavito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Michael Garavito more than expected).
Fields of papers citing papers by R. Michael Garavito
This network shows the impact of papers produced by R. Michael Garavito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Michael Garavito. The network helps show where R. Michael Garavito may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. Michael Garavito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 24 | |
| 2 | 2014 | 101 | |
| 3 | 2013 | 338 | |
| 4 | 2011 | 13 | |
| 5 | 2011 | 5 | |
| 6 | 2009 | 38 | |
| 7 | 2008 | 46 | |
| 8 | 2008 | 30 | |
| 9 | 2007 | 90 | |
| 10 | 2007 | 321 | |
| 11 | 2007 | 49 | |
| 12 | 2001 | 9 | |
| 13 | 2001 | 97 | |
| 14 | 1999 | 17 | |
| 15 | 1999 | 130 | |
| 16 | 1995 | 168 | |
| 17 | 1995 | 86 | |
| 18 | 1995 | 11 | |
| 19 | 1995 | 36 | |
| 20 | 1986 | 144 |
About R. Michael Garavito
R. Michael Garavito is a scholar working on Biochemistry, Pharmacology and Structural Biology, having authored 105 papers that have together received 13.0k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (28 papers), Enzyme Structure and Function (22 papers), Lipid Membrane Structure and Behavior (19 papers), Protein Structure and Dynamics (14 papers), Photosynthetic Processes and Mechanisms (12 papers), Estrogen and related hormone effects (11 papers), RNA and protein synthesis mechanisms (10 papers) and Eicosanoids and Hypertension Pharmacology (9 papers). The work is most often cited by research in Pharmacology (4.9k citations), Biochemistry (1.7k citations) and Pharmacology (788 citations). R. Michael Garavito has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include William L. Smith, David L. DeWitt, Daniel Picot, Patrick J. Loll, Shelagh Ferguson‐Miller, A. M. Mulichak, W. Villiger, Eric Carlemalm, Jürg P. Rosenbusch and Michael G. Malkowski. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.